BioMarin Pharmaceuticals BMRN Gross margin

Gross margin at other companies

Zevra Therapeutics, Inc.ZVRA

95.5%+23.5pp

Agios PharmaceuticalsAGIO

92%+3.8pp

RegenxbioRGNX

59.7%+1.0pp

BridgeBio PharmaBBIO

95.1%-0.2pp

Crinetics PharmaceuticalsCRNX

150%-15.6pp

XER

Xeris Biopharma Holdings, Inc.XERS

86.6%+4.3pp

FAQ

What is BioMarin Pharmaceuticals's gross margin?

BioMarin Pharmaceuticals (BMRN) reported gross margin of 76.1% in Q2 2026.

How has BioMarin Pharmaceuticals's gross margin changed year-over-year?

BioMarin Pharmaceuticals's gross margin decreased by 4.3% year-over-year, from 79.6% to 76.1%.

What is the long-term trend for BioMarin Pharmaceuticals's gross margin?

Over 5 years (2020 to 2025), BioMarin Pharmaceuticals's gross margin has grown at a 1.6% compound annual growth rate (CAGR), from 71.8% to 77.7%.

What does gross margin mean?

Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.